MedPath

Platelet-Rich Fibrin in the Healing of Regional and Free Flaps

Not Applicable
Completed
Conditions
Head and Neck Disorder
Free Flap
Interventions
Procedure: Platelet Rich Fibrin (PRF) Application
Registration Number
NCT04023474
Lead Sponsor
University of Florida
Brief Summary

Determine if the use of platelet-rich fibrin (PRF) versus historical treatment methods improves the post-operative management of healing complications from flap donor sites.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3
Inclusion Criteria
  • Patients who had surgery involving a microvascular free flap or a myocutaneous regional flap for head and neck reconstruction who develop one of the following donor site complications: wound dehiscence, wound margin breakdown or contraction resulting in healing by secondary intention, myocutaneous fistula formation, or incomplete coverage of the donor site by a skin graft placed in the operating room.
Read More
Exclusion Criteria
  • Patients under 18 years of age
  • Patient's unable to participate in blood draw either due to medical compromise, inability to tolerate the procedure, or inability of the physician to successfully draw the blood at the time of appointment.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Platelet Rich Fibrin (PRF) GroupPlatelet Rich Fibrin (PRF) ApplicationPatients randomized to this group will receive treatment with a PRF graft in clinic at the time any pertinent post-operative complication is identified.
Primary Outcome Measures
NameTimeMethod
Change in healing time at 3 months post-operativeUp to 3 months

Improved healing of PRF patients compared to control group.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UF Health Jacksonville

🇺🇸

Jacksonville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath